An early study revealed no changes in iron or transferrin levels in the CSF between MS and controls [73], while CSF/serum ferritin levels were significantly elevated in chronic progressive MS patients compared to controls and RR patients [43,73]. The gene discussed is TF; the disease is myeloid sarcoma.